Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12>>>
30 Items
Title  Creator  Group name  Publishing year 
Learning curve for robotic-assisted total mesorectal excision: a multicentre, prospective study Arquillière et al. EquipeCTCS 2023-09
Robotic-assisted colon resection for splenic flexure cancer Bourla et al. EquipeCTCS 2022-06
An anatomical variation during para-aortic lymphadenectomy Leborne et al. EquipeCTCS 2022-06-01
On skin dose estimation software in interventional radiology Colombo et al. EquipeCTCS 2021-01
Management of diaphragmatic peritoneal metastasis from recurrent ovarian cancer with pericardial invasion Carrier et al. EquipeCTCS 2021-02
Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study Houvenaeghel et al. EquipeCTCS 2021-12
Automatic lung segmentation in COVID-19 patients: Impact on quantitative computed tomography analysis Berta et al. EquipeCTCS 2021-07
A patient-specific approach for quantitative and automatic analysis of computed tomography images in lung disease: Application to COVID-19 patients Berta et al. EquipeCTCS 2021-02
Robotic distal pancreatectomy with splenectomy for pancreatic neuroendocrine tumor (with video) Carrier et al. EquipeCTCS 2020-06
[CHIP and ovarian cancer] Lécuru et al. EquipeCTCS Jun 26, 2019
Robotic colon resection for splenic flexure cancer with intracorporeal anastomosis (with video) Carrier et al. EquipeCTCS Jul 16, 2019
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study Martinez et al. EquipeCTCS Feb 2018
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study de Nonneville et al. EquipeCTCS 10 2017
Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients Colombo et al. EquipeCTCS Dec 29 2016
Standardized single docking, four arms and fully robotic proctectomy for rectal cancer: the key points are the ports and arms placement Bertrand et al. EquipePM Dec 8 2015
Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure Colombo et al. EquipeCTCS Sep 29 2015
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers Jacot et al. EquipeCTCS 2015
[Lymph node dissection: what for? From esophagus to rectum: surgical and lymph node related prognostic factors] Alline et al. EquipeCTCS Apr 2014
[Breast surgeon role in the management of high-risk breast lesions] Colombo et al. EquipeCTCS Jul-Aug 2014
Versatile UCST-based thermoresponsive hydrogels for loco-regional sustained drug delivery Boustta et al. EquipeCTCS Jan 28 2014
Transanal endoscopic proctectomy and nerve injury risk: bottom to top surgical anatomy, key points Bertrand et al. EquipeCTCS Sep 2014
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer Saadoun et al. EquipeCTCS Feb 2014
Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer Colombo et al. EquipeCTCS Nov 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models Thomas et al. EquipeMY Aug 30 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models Thomas et al. EquipeCTCS Aug 30 2014
12>>>
30 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés